All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Targeting of somatic hypermutation by the interplay of transcriptional kinetics and DNA repair fidelity

Public support

  • Provider

    Czech Science Foundation

  • Programme

    Standard projects

  • Call for proposals

    SGA0202600001

  • Main participants

    Ústav molekulární genetiky AV ČR, v. v. i.

  • Contest type

    VS - Public tender

  • Contract ID

    26-23400S

Alternative language

  • Project name in Czech

    Targeting of somatic hypermutation by the interplay of transcriptional kinetics and DNA repair fidelity

  • Annotation in Czech

    Somatic hypermutation (SHM) is a key process in diversification of antibodies. This process is initiated by cytosine deamination by the activation-induced cytidine deaminase (AID) and completed by error-prone processing of the resulting uracils. Although SHM aims primarily to Ig loci, frequent targeting of non-Ig loci has been reported, accentuating the role of SHM in lymphomagenesis. We developed a series of novel methods providing data on SHM susceptibility in the B cell genome and identifying a series of factors involved in SHM. Based on our preliminary results, we propose a model of SHM targeting that combines the roles of AID access to various genomic regions and site-specific variability of error-proneness of DNA repair. Our novel approach will decipher the transcriptional kinetic features involved in targeting of AID activity and identify factors responsible for specific distribution of cytidine deamination and high error rate of DNA repair in SHM-targeted regions. Our study will provide a novel insight into the mechanism of SHM targeting and its involvement in lymphomagenesis

Scientific branches

  • R&D category

    ZV - Basic research

  • OECD FORD - main branch

    30102 - Immunology

  • OECD FORD - secondary branch

  • OECD FORD - another secondary branch

  • CEP - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    EC - Immunology

Solution timeline

  • Realization period - beginning

    Jan 1, 2026

  • Realization period - end

    Dec 31, 2028

  • Project status

    Z - Beginning multi-year project

  • Latest support payment

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP26-GA0-GA-R

  • Data delivery date

    Apr 27, 2026

Finance

  • Total approved costs

    8,968 thou. CZK

  • Public financial support

    8,968 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK